Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States

Emerging Infectious Diseases

Volumn 20, Issue 7, 2014, Pages 1183-1190

  Krause, Peter J ^a,b   Narasimhan, Sukanya ^a,b   Wormser, Gary P ^c   Barbour, Alan G ^d   Platonov, Alexander E ^e   Brancato, Janna ^a   Lepore, Timothy ^f   Dardick, Kenneth ^g   Mamula, Mark ^a,b   Rollend, Lindsay ^a   Steeves, Tanner K ^a   Diuk Wasser, Maria ^a   Usmani Brown, Sahar ^h   Williamson, Phillip ⁱ   Sarksyan, Denis S ^j   Fikrig, Erol ^a,b   Fish, Durland ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

^f Nantucket Cottage Hospital   (United States)

^g Mansfield Family Practice   (United States)

^h L2 Diagnostics LLC   (United States)

ⁱ CREATIVE TESTING SOLUTIONS   (United States)

^j IZHEVSK STATE MEDICAL ACADEMY   (Russian Federation)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANTIBODY DETECTION; ARTICLE; BACTERIUM; BORRELIA BURGDORFERI; BORRELIA INFECTION; BORRELIA MIYAMOTOI; CHILD; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; IMMUNOASSAY; IXODES SCAPULARIS; LYME DISEASE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PIROPLASMOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHIAN REACTION; SEROLOGY; SEROPREVALENCE; TICK; TICK BORNE DISEASE; WESTERN BLOTTING; BLOOD; BORRELIA; BORRELIA INFECTIONS; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; UNITED STATES;

ANTIBODIES, BACTERIAL; BORRELIA; BORRELIA INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYME DISEASE; MALE; MIDDLE AGED; NEW ENGLAND; SEROEPIDEMIOLOGIC STUDIES;

EID: 84902826075     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2007.131587     Document Type: Article

References (32)

1. Barbour AG. Relapsing fever. In: Goodman JL, Dennis DT, Sonenshine DE, editors. Tick-borne diseases of humans. Washington (DC): ASM Press; 2005.
2. Dworkin MS, Schwan TG, Anderson DE. Tick-borne relapsing fever in North America. Med Clin North Am. 2002;86:417-33. http://dx.doi.org/10.1016/S0025-7125(03)00095-6
3. Fukunaga M, Takahashi Y, Tsuruta Y, Matsushita O, Ralph D, McClelland M, et al. Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol. 1995;45:804-10. http://dx.doi.org/10.1099/00207713-45-4-804
4. Scoles GA, Papero M, Beati L, Fish D. A relapsing fever group spirochete transmitted by Ixodes scapularis ticks. Vector Borne Zoonotic Dis. 2001;1:21-34. http://dx.doi.org/10.1089/153036601750137624
5. Bunikis J, Tsao J, Garpmo U, Berglund J, Fish D, Barbour AG. Typing of Borrelia relapsing fever group strains. Emerg Infect Dis. 2004;10:1661-4. http://dx.doi.org/10.3201/eid1009.040236
6. Barbour AG, Bunikis J, Travinsky B, Hoen AG, Diuk-Wasser MA, Fish D, et al. Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species. Am J Trop Med Hyg. 2009;81:1120-31. http://dx.doi.org/10.4269/ ajtmh.2009.09-0208
7. Mun J, Eisen RJ, Eisen L, Lane RS. Detection of a Borrelia miyamotoi sensu lato relapsing-fever group spirochete from Ixodes pacificus in California. J Med Entomol. 2006;43:120-3. http://dx.doi. org/10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2
8. Richter D, Schlee DB, Matuschka FR. Relapsing fever-like spirochetes infecting European vector tick of Lyme disease agent. Emerg Infect Dis. 2003;9:697-701. http://dx.doi.org/10.3201/eid0906.020459
9. Platonov AE, Karan LS, Kolyasnikova NM, Makhneva N, Toporkova MG, Maleev VV, et al. Humans infected with the relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis. 2011;17:1816-23. http://dx.doi.org/10.3201/eid1710.101474
10. Gugliotta JL, Goethert HK, Berardi VP, Telford SR. Meningoencephalitis due to Borrelia miyamotoi in an elderly immunocompromised patient. N Engl J Med. 2013;368:240-5. http://dx.doi. org/10.1056/NEJMoa1209039
11. Krause PJ, Narasimhan S, Wormser GP, Rollend L, Fikrig E, Lepore T, et al. Human Borrelia miyamotoi infection in the United States. N Engl J Med. 2013;368:291-3. http://dx.doi.org/10.1056/NEJMc1215469
12. Chowdri HR, Gugliotta JL, Berardi V, Goethert H, Molloy PJ, Sterling SL, et al. Borrelia miyamotoi presenting as human granulocytic anaplasmosis. A case report. Ann Intern Med. 2013;159:21-7. http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00005
13. Hovius JW, de Wever B, Sohne M, Brouwer M, Coumou J, Wagemakers A, et al. A case of meningoencephalitis by the relapsing fever spirochete Borrelia miyamotoi in Europe. Lancet. 2013;382:658. http://dx.doi.org/10.1016/S0140-6736(13)61644-X
14. Sarksyan DS, Platonov AE, Karan LS, Malinin IE, Khaliltova LI, Shakhov VI, et al. Clinical presentation of "new" tick-borne borreliosis caused by Borrelia miyamotoi [In Russian]. Ter Arkh. 2012;84:34-41.
15. Schwan TG, Schrumpf ME, Hinnebusch BJ, Anderson DE, Konkel ME. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol. 1996;34:2483-92.
16. Krause PJ, McKay K, Gadbaw J, Christianson D, Closter L, Lepore T, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg. 2003;68:431-6.
17. Horowitz HW, Aguero-Rosenfeld ME, Holmgren D, McKenna D, Schwartz I, Cox ME, et al. Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis. 2013;56:93-9. http://dx.doi.org/10.1093/cid/cis852
18. Barbour AG, Jasinskas A, Kayala MA, Davies DH, Steere A, Baldi P, et al. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun. 2008;76:3374-89. http://dx.doi.org/10.1128/IAI.00048-08
19. Hue F, Ghalyanchi Langeroudi A, Barbour AG. Chromosome sequence of Borrelia miyamotoi, an uncultivable tick-borne agent of human infection. Genome Announc. 2013;1:e00713-13. http:// dx.doi.org/10.1128/genomeA.00713-13
20. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol. 1999;37:3990-6.
21. Magnarelli LA, Meegan JM, Anderson JF, Chappell WA. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol. 1984;20:181-4.
22. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392-400. http://dx.doi.org/10.1093/infdis/167.2.392
23. Bacon RM, Biggerstaff BJ, Schreifer M, Gilmore RD, Philipp MT, Steere AC, et al. Serodiagnosis of Lyme disease by kinetic enzymelinked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187:1187-99. http://dx.doi.org/10.1086/374395
24. Magnarelli LA, Anderson JF, Johnson RC. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis. 1987;156:183-8. http://dx.doi.org/10.1093/ infdis/156.1.183
25. Magnarelli LA, Lawrenz M, Norris SJ, Fikrig E. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol. 2002;51:649-55.
26. Johnson ST, Cable RG, Tonnetti L, Spencer B, Rios J, Leiby DA. Seroprevalence of Babesia microti in blood donors from Babesiaendemic areas of the northeastern United States: 2000 through 2007. Transfusion. 2009;49:2574-82. http://dx.doi.org/10.1111/j.1537- 2995.2009.02430.x
27. Krause PJ, Telford S, Spielman A, Sikand VJ, Ryan R, Christianson D, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA. 1996;275:1657-60. http://dx.doi.org/10.1001/jama.1996.03530450047031
28. Krause PJ, McKay K, Thompson CA, Sikand VJ, Lentz R, Lepore T, et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis. 2002;34:1184-91. http://dx.doi. org/10.1086/339813
29. Ackermann R, Kabatzki J, Boisten HP, Steere AC, Grodzicki RL, Hartung S, et al. Ixodes ricinus spirochete and European erythema chronicum migrans disease. Yale J Biol Med. 1984;57:573-80.
30. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1-55.
31. Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell. 1997;89:275-85. http://dx.doi. org/10.1016/S0092-8674(00)80206-8
32. Salkeld DJ, Cinkovich S, Nieto NC. Tick-borne pathogens in northwestern California, USA [letter]. Emerg Infect Dis. 2014;20:493-4. http://dx.doi.org/10.3201/eid2003.130668